Comera Life Sciences Inc. has agreed to go public through a merger with OTR Acquisition Corp., a blank-check company.
The combined company will have an initial equity value of about $258.4 million, according to a statement seen by Bloomberg. It will provide about $107 million in gross cash proceeds, the companies said.
